SCHEMBL9123460

SCHEMBL9123460

CC(=NNC(=S)NNC(=S)NC(=O)c1ccccc1)c1ccccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AGTR1 P30556 8/20 0.62
▸ NPC1 O15118 8/20 0.62
▸ RAB9A P51151 7/20 0.62
▸ OPRK1 P41145 4/20 0.61
▸ L3MBTL1 Q9Y468 1/20 0.61
▸ TOP2A P11388 2/20 0.61
▸ SLC2A1 P11166 2/20 0.57
▸ GAA P10253 5/20 0.56
▸ MAPT P10636 2/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ KMT2A Q03164 4/20 0.55
▸ MEN1 O00255 2/20 0.55
▸ PKM P14618 1/20 0.55
▸ POLB P06746 1/20 0.54
▸ MITF O75030 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28431272 0.82 KDM4E (0.62) NPC1RAB9AL3MBTL1GAAMAPT
SCHEMBL12720817 0.79 NPC1 (0.76) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL30454796 0.79 TOP2A (0.68) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL9120443 0.78 TOP2A (0.60) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL12218079 0.77 AGTR1 (1.00) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL30826082 0.77 AGTR1 (1.00) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL15882844 0.77 AGTR1 (1.00) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL17438145 0.77 AGTR1 (1.00) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL29883013 0.76 TOP2A (1.00) AGTR1NPC1RAB9AOPRK1L3MBTL1
SCHEMBL17987719 0.76 TOP2A (1.00) AGTR1NPC1RAB9AOPRK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5393883-A Ribonucleotide reductase inhibitors BURROUGHS WELLCOME CO. (US) 1995-02-28 — — US disclosed
US-5175165-A Acyclovir and a thiocarbonohydrazone ribonucleotide reductase inhibitor for treatment of herpes virus BURROUGHS WELLCOME CO. (US) 1992-12-29 — — US disclosed
EP-0349243-B1 ANTIVIRAL COMBINATIONS AND COMPOUNDS THEREFOR THE WELLCOME FOUNDATION LIMITED (GB) 1992-04-01 — — EP disclosed
EP-0349243-A2 Antiviral combinations and compounds therefor THE WELLCOME FOUNDATION LIMITED (GB) 1990-01-03 — — EP disclosed
Send feedback